ArticleAnnals of vascular surgery2025
The Natural History of Peripheral Arterial Disease Following Lower Extremity Revascularization at a Single Institution.
Article in Annals of vascular surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundPeripheral artery disease (PAD) is widely prevalent, affecting more than 200 million people worldwide. However, the natural history of this disease process following lower extremity revascularization has not been fully delineated. We aimed to analyze this disease process with particular attention to subsequent interventions, wound complications, and mortality.
methodsWe conducted a prospective single-institution study that included patients who underwent lower extremity revascularization for PAD at our institute from December 2020 to December 2023. Patients were followed from the time of their index surgery through March 2024 or until they were lost to follow-up. Major events after the index revascularization were documented and analyzed.
resultsThe study included 277 patients (35% female) with a mean age of 69 years. In this cohort, 21.3% of patients required postsurgical revascularization. Initial vascular complications occurred in 16% of patients, with 11% experiencing occlusion and 5% developing stenosis, while site-specific complications affected 10% of cases. Amputation was necessary in 11% of patients, primarily driven by worsening wounds (48%) and infection (23%). Secondary complications included bleeding events (9%), infection/wound dehiscence (5%), and thrombotic events (1%). The study revealed a 10% mortality rate, with patients surviving an average of 4.4 months post surgery.
conclusionWe found that 21.3% of patients required at least one additional surgical revascularization of the ipsilateral leg, and the overall mortality rate during the study follow-up period was 10%. Knowledge of the risks of morbidity, mortality, and progression of disease can help vascular surgeons counsel patients undergoing lower extremity revascularization for PAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.